A Bioequivalence Study of APX001 High-load and Low-load Tablets

NCT05491733 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Invasive Fungal Infections

Interventions

DRUG: APX001
DRUG: APX001A

Sponsor

Basilea Pharmaceutica